Drug Interaction Report
2 potential interactions and/or warnings found for the following 2 drugs:
- tolazoline
- Uroxatral (alfuzosin)
Interactions between your drugs
tolazoline alfuzosin
Applies to: tolazoline, Uroxatral (alfuzosin)
Using alfuzosin together with tolazoline is not recommended. Combining these medications may cause blood pressure to fall excessively and heart rate to increase, especially when you rise from a sitting or lying position. The risk of other side effects such as dizziness, lightheadedness, fainting, headache, flushing, nasal congestion, heart palpitations, and priapism (prolonged and painful erection unrelated to sexual activity) may also increase. These side effects can occur with either medication alone and are most likely to be seen at the beginning of treatment, following a dose increase, or when treatment is restarted after an interruption. Let your doctor know if you develop these symptoms and they do not go away on their own or they become troublesome. Avoid driving or operating hazardous machinery until you know how the medication affects you, and use caution when getting up from a sitting or lying position. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Drug and food/lifestyle interactions
alfuzosin food/lifestyle
Applies to: Uroxatral (alfuzosin)
Food can enhance the levels of alfuzosin in your body. Alfuzosin should be taken just after eating food. This will make it easier for your body to absorb the medication. Take alfuzosin after the same meal each day. Do not take it on an empty stomach.
Therapeutic duplication warnings
No duplication warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Camzyos
Camzyos (mavacamten) is a treatment for obstructive hypertrophic cardiomyopathy (HCM) . Includes ...
Corlanor
Corlanor (ivabradine) is used for the treatment of chronic heart failure. Corlanor information ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Filspari
Filspari is used for primary immunoglobulin A nephropathy (IgAN), to slow kidney function decline ...
OraVerse
OraVerse is used for reversal of dental anesthesia. Learn about side effects, interactions and ...
Orvaten
Orvaten is used for dysautonomia, hypotension, postural orthostatic tachycardia syndrome
Learn more
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.